- TOP
- ã³ã©ã TOP
- CBGã®å¹æãšã¯ïŒCBDãšã®éããéæ³æ§ã«ã€ããŠè§£èª¬
CBGã®å¹æãšã¯ïŒCBDãšã®éããéæ³æ§ã«ã€ããŠè§£èª¬
CBGïŒã«ã³ããã²ããŒã«ïŒãšã¯ã倧麻èã«å«ãŸããååç©ã®äžçš®ã§ãã«ã³ãããã€ããšåŒã°ããæåã®äžã€ã§ãã
倧麻ã«å«ãŸããã«ã³ãããã€ãã®äžã§ãæ°ããæ³šç®ãéããŠããæåã§ãããæççäœçšãæé
žåäœçšã飿¬²å¢é²äœçšãšãã£ã广ãæåŸ
ãããŠããŸãã
æ¬èšäºã§ã¯ãCBGã®å¹æã«å ããéæ³æ§ãCBDãšã®éãã«ã€ããŠè©³ãã解説ããŸãã
CBGïŒã«ã³ããã²ããŒã«ïŒãšã¯ïŒ
CBGã¯ãCannabigerolïŒã«ã³ããã²ããŒã«ïŒãã®ç¥ç§°ã§ã倧麻èã«å«ãŸããã«ã³ãããã€ãã®äžçš®ã§ãã
ã«ã³ãããã€ããšã¯ã倧麻æ€ç©ã«å«ãŸããååç©ã®ç·ç§°ã§ãCBDïŒã«ã³ãããžãªãŒã«ïŒãªã©ããã®ä»£è¡šäŸãšããŠç¥ãããŠããŸãã
çŸåš104çš®é¡ã確èªãããŠããããã®äžã§CBGã¯ãã«ã³ãããã€ãã®æ¯ããšåŒã°ããŠããŸãã
ãã®çç±ã¯ãCBGãCBDãTHCãªã©ã®ä»ã®äž»èŠãªã«ã³ãããã€ãã®ããšã«ãªãããã§ãã
CBGã«ã¯æ°åããã€ã«ãªããããªç²Ÿç¥äœçšãäžæ¯æ§ã¯ãããŸãããè¿å¹Žã§ã¯å»çåéã§ã泚ç®ãéããŠããŸãã
CBGã®éæ³æ§
CBGïŒã«ã³ããã²ããŒã«ïŒã¯ã倧麻èã«å«ãŸããäžæ¯æ§ããªãã«ã³ãããã€ãã§ãæ¥æ¬ã§ã¯åæ³ã§ãã
ãã ãã麻è¬åã³å粟ç¥è¬åç· æ³ã®äžé𿹿£ã«ããã倧麻ã«å«ãŸããTHCïŒããã©ãããã«ã³ããããŒã«ïŒãšããæåã麻è¬ãšããŠåãç· ãŸãããããšã«ãªããCBG補åã«å«ãŸããTHCã®åºæºãããå³ãããªããŸããã
| çš®é¡ | 補åäŸ | THCã®æ®çéåºŠå€ |
|---|---|---|
| é£çšæ²¹èïŒåžžæž©ã§æ¶²äœïŒ ç²æ« |
ãªã€ã«ãããŠããŒããããã€ã³ãªã© | 10ppmïŒ0.001ïŒ ïŒ |
| 飲æ | æž æ¶Œé£²ææ°Žãã¢ã«ã³ãŒã«é£²æãåç²§æ°Žãªã© | 0.1ppmïŒ0.00001ïŒ ïŒ |
| ãã®ä» | é»åã¿ãã³ãèåãé å€ã乳液ãã·ã£ã³ããŒããªã³ã¹ãªã© | 1ppmïŒ0.0001ïŒ ïŒ |
補åãéžã¶éã«ã¯ãä¿¡é Œã§ããã¡ãŒã«ãŒã販売å
ãã賌å
¥ããæå衚瀺ããã£ãã確èªããããã«ããŸãããã
åºå
žïŒã什å6幎12æ12æ¥ã«ã倧麻åç· æ³åã³éº»è¬åã³å粟ç¥è¬åç· æ³ã®äžéšãæ¹æ£ããæ³åŸãã®äžéšãæœè¡ãããŸããïŒåçåŽåçïŒ
ãCBDïŒã«ã³ãããžãªãŒã«ïŒãå«ãé»åã¿ãã³ãå¥åº·é£åçã¯å€§éº»æå THC ãå«ãŸããŠããããããããããããæ³šæãã ãããïŒæ±äº¬éœæ¶è²»ç掻ç·åã»ã³ã¿ãŒïŒ
CBGãšCBDã®éã
CBGïŒã«ã³ããã²ããŒã«ïŒãšCBDïŒã«ã³ãããžãªãŒã«ïŒã¯ãã©ã¡ãã倧麻èã«å«ãŸãã粟ç¥äœçšãäžæ¯äœçšããªãã«ã³ãããã€ãã§ãããããããç°ãªãç¹åŸŽã广ãæã£ãŠããŸãã
| ç¹åŸŽ | äž»ãªå¹æ | åžå°æ§ | |
|---|---|---|---|
| CBG ïŒã«ã³ããã²ããŒã«ïŒ |
CBDãTHCãªã©ã®ä»ã®äž»èŠãªã«ã³ãããã€ãã®ããšã«ãªããã® | ãªã©ãã¯ã¹ãã¹ãã¬ã¹è»œæžãèãã©ãã«ã®ã±ã¢ã飿¬²å¢é² | åžå°æ§ãé«ããã³ã¹ããããã |
| CBD ïŒã«ã³ãããžãªãŒã«ïŒ |
麻ïŒå€§éº»èïŒã®èãçš®åããæœåºãããã«ã³ãããã€ããšåŒã°ããæåã®äžçš® | ãªã©ãã¯ã¹ãã¹ãã¬ã¹è»œæžãççã®æå¶ãäžå®ã®ç·©å | CBDãšæ¯èŒãããšåžå°æ§ãäœã |
CBGã¯ã倧麻èã®æé·éçšã§CBDãTHCãªã©ã®ã«ã³ãããã€ããçã¿åºãããšãšãªãããããã«ã³ãããã€ãã®æ¯ããšåŒã°ããŠããŸãã
CBGã®æœåºã«ã¯æéãããããåžå°æ§ãé«ãã³ã¹ããé«ãããšãç¹åŸŽã§ãã
äžæ¹ãCBDã¯æçãã倧麻èã«å€ãå«ãŸããæåã§ãæ¯èŒçæœåºãããããããæé ãªäŸ¡æ Œã§å
¥æã§ããŸãã
ã©ã¡ãããªã©ãã¯ã¹å¹æãã¹ãã¬ã¹è»œæžãšãã£ã广ãæåŸ
ãããŸãããCBGã¯ç¹ã«é£åãçŸå®¹åéã§æ³šç®ãããŠããŸãã
ããããã®ç¹æ§ãçè§£ããç®çã«åã£ãæåãéžã¹ã°ããã广çã«æŽ»çšã§ããŸãã
CBDã«ã€ããŠãã詳ããç¥ãããæ¹ã¯ãäžèšã®èšäºãåèã«ããŠãã ããã
ãCBDãšã¯ïŒéæ³æ§ã广ãªã©æ°ã«ãªãçåã解説ã
CBGã®å¹æ
CBGã®å¹æãšããŠæåŸ
ãããŠãããã®ã«ã¯ã以äžã®5ã€ããããŸãã
- æççäœçš
- æé žåäœçš
- ç¥çµä¿è·äœçš
- æ°åãæŽãã
- 飿¬²ãå¢é²ããã
ãããã詳ãã解説ããŠãããŸãã
æççäœçš
CBGã¯ãäœå
ã®ECSïŒãšã³ãã«ã³ãããã€ãã·ã¹ãã ïŒã«åããããççãæå¶ãã广ããããšãããŠããŸãã
ECSãšã¯ãäœå
ã®å
ç«æ©èœãçã¿ã®èª¿ç¯ã«é¢äžããäœå
ã®ã·ã¹ãã ã§ãã
ãã®ç¹æ§ã«ãããé¢ç¯çãççæ§è
žçŸæ£ãããã«ã¯ç®èçŸæ£ãªã©ãççãåå ãšãªãããŸããŸãªçç¶ã®ç·©åã«åœ¹ç«ã€å¯èœæ§ããããŸãã
ãŸããæççäœçšã«ãããçã¿ã軜æžãã广ã瀺åãããŠããŸãã
åèïŒNachnani, R., Raup-Konsavage, W. M., & Vrana, K. E. The pharmacological case for cannabigerol (CBG). Journal of Pharmacology and Experimental Therapeutics, 2020, JPET-MR-2020-000340.
æé žåäœçš
CBGïŒã«ã³ããã²ããŒã«ïŒã«ã¯æé
žåäœçšããããäœå
ã§çºçããæŽ»æ§é
žçŽ ïŒããªãŒã©ãžã«ã«ïŒãé€å»ãããã®æªåœ±é¿ãæããåããæåŸ
ãããŠããŸãã
掻æ§é
žçŽ ã¯ãã¹ãã¬ã¹ã玫å€ç·ãäžèŠåãªçæŽ»ç¿æ
£ãªã©ã«ãã£ãŠå¢å ãã现èãå·ã€ããããšã§èåãç
æ°ã®åå ãšãªãç©è³ªã§ãã
CBGã¯ãã®æŽ»æ§é
žçŽ ãäžåããèœåãæã€ãšãããé
žåã¹ãã¬ã¹ã軜æžããããšã§çްèãä¿è·ãã广ãæåŸ
ãããŠããŸãã
ãã®ãããCBGã¯å¥åº·ç¶æãã¢ã³ããšã€ãžã³ã°ã®åéã§æ³šç®ãããæåã§ãã
åèïŒã倧麻ã«é¢ããåŠè¡è«æãïŒå»è¬åã»å»çæ©åšçã¬ã®ã¥ã©ããªãŒãµã€ãšã³ã¹æ¿çå»è¬åïŒ
ç¥çµä¿è·äœçš
CBGïŒã«ã³ããã²ããŒã«ïŒã¯ãç¥çµä¿è·äœçšããããšãããè³ãç¥çµç³»ã®å¥åº·ããµããŒãããå¹æãæ³šç®ãããŠããŸãã
2015幎ã®ç ç©¶ã§ã¯ããã³ãã³ãã³ç
ã«çœ¹æ£ããããŠã¹ã«CBGãæäžãããã®æçšæ§ãæ€èšŒããå®éšãè¡ãããŸããã
ãã³ãã³ãã³ç
ãšã¯ãæå¿ãšé¢ä¿ãªãäœãåãä»ééåãè¡åç°åžžã䌎ãç¥çµå€æ§çŸæ£ã®äžçš®ã§ãã
å®éšã®çµæãCBGãæäžãããããŠã¹ã§ã¯çç¶ã®æ¹åãèŠããããã³ãã³ãã³ç
ã«å¯ŸããŠææãªå埩ãå ±åãããŠããŸãã
åèïŒValdeolivas, S., Navarrete, C., Cantarero, I., Bellido, M. L., Muñoz, E., & Sagredo, O. Neuroprotective properties of cannabigerol in Huntingtonâs disease: studies in R6/2 mice and 3-nitropropionate-lesioned mice. Neurotherapeutics, 2015, 12(1), 185-199.
æ°åãæŽãã
CBGïŒã«ã³ããã²ããŒã«ïŒã¯ãæ°åãæŽããå¹æãæ³šç®ãããŠããŸãã
å
·äœçã«ã¯ä»¥äžã®ãããªå¹æãæåŸ
ãããŸãã
ã»ã¹ãã¬ã¹è»œæž
ã¹ãã¬ã¹ãã«ã¢ã³ã§ããã³ã«ããŸãŒã«ã®éå°åæ³ãæãããªã©ãã¯ã¹ããç¶æ
ãä¿ãã
ã»äžå®æã®ç·©å
ç¥çµäŒéç©è³ªã®ãã©ã³ã¹ãæŽããããšã§ãäžå®ãç·åŒµæãåãããã
ã»ããžãã£ããªæ°åãžã®ãµããŒã
æ°åãèœã¡çããã ãã§ãªããååããªææ
ãåŒãåºãå©ããšãªãã
åèïŒBergamaschi, M. M., Queiroz, R. H. C., Chagas, M. H. N., Oliveira, D. C. G., De Martinis, B. S., Kapczinski, F., Quevedo, J., Roesler, R., Schröder, N., Nardi, A. E., MartÃn-Santos, R., Hallak, J. E. C., Zuardi, A. W., & Crippa, J. A. S. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. Neuropsychopharmacology, 2011, 36(6), 1219â1226.
飿¬²ãå¢é²ããã
CBGïŒã«ã³ããã²ããŒã«ïŒã¯ã飿¬²ãå¢é²ããã广ãæåŸ
ãããŠããŸãã
2016幎ã«è¡ãããå®éšã§ã¯ãæºè
¹ç¶æ
ã®ããŠã¹ãè€æ°ã®ã°ã«ãŒãã«åããŠCBGãæäžãããšãããCBGã®æäžéãå€ãã°ã«ãŒãã»ã©ç·é£ç©æåéãå¢å ã
é£ã¹å§ãããŸã§ã®æéãççž®ããããšããçµæãåŸãããŸããã
ãã®ãããªç¹æ§ãããCBGã¯é£æ¬²äžæ¯ã«æ©ã人ãäœéãå¢ãããã人ã«ãšã£ãŠæçšãªæåãšãããå»çåéã§ã泚ç®ãéããŠããŸãã
åèïŒBrierley, D. I., Samuels, J., Duncan, M., Whalley, B. J., & Williams, C. M. âCannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats.â Psychopharmacology, 2016, Vol. 233, Issue 19-20, pp. 3603-3613.
CBGãåããŠãã人ã®ç¹åŸŽ
CBGïŒã«ã³ããã²ããŒã«ïŒãåããŠãã人ã®ç¹åŸŽã解説ããŸãã
CBGã®å¹æãç¹æ§ãæ£ããçè§£ããèªåã«åã£ãäœ¿ãæ¹ãèŠã€ããããšã§ãæ¥åžžç掻ã®è³ªãããåäžãããããšãã§ããã§ãããã
ã»æ
¢æ§çãªççãçã¿ã«æ©ãã§ããæ¹
CBGã«ã¯æçç广ããããããé¢ç¯çãççæ§è
žçŸæ£ãã¢ãããŒæ§ç®èçãªã©ã®çç¶ãåãããå¯èœæ§ãæåŸ
ãããŠããŸããæ
¢æ§çãªççãçã¿ã«æ©ãæ¹ã¯è©ŠããŠã¿ã䟡å€ããããããããŸããã
ã»æ°åã®å®å®ãã¹ãã¬ã¹è»œæžãæ±ããŠããæ¹
CBGã¯ããšã³ãã«ã³ãããã€ãã·ã¹ãã ïŒECSïŒã調æŽããããšã§ãæ°åãå®å®ããã广ãæåŸ
ãããŠããŸããECSã¯äœå
ã®ç¥çµäŒéãå
ç«å¿çãã¹ãã¬ã¹ç®¡çãªã©ã«é¢äžããéèŠãªã·ã¹ãã ã§ãç§ãã¡ã®å¿èº«ã®ãã©ã³ã¹ãä¿ã€åœ¹å²ãæãããŠããŸãã
ã»é£æ¬²äžæ¯ãäœéæžå°ã«æ©ãæ¹
飿¬²ãå¢é²ãããäœçšããããããç
æ°ãæ²»çã®å¯äœçšã§é£æ¬²ãäœäžããŠããæ¹ãå¥åº·çã«äœéãå¢ããããæ¹ã«ããããã§ãã
ã»çŸå®¹ããšã€ãžã³ã°ã±ã¢ããããæ¹
CBGã®æé
žåäœçšã¯ãäœã®é
žåã¹ãã¬ã¹ã軜æžããèã现èã®èåãé²ãå©ããšãªãå¯èœæ§ããããŸãããšã€ãžã³ã°ã±ã¢ãç®æããŠããæ¹ã«é©ããŠããŸãã
CBGã®å±éºæ§ã»å¯äœçš
CBGïŒã«ã³ããã²ããŒã«ïŒã¯å€æ§ãªå¹æã泚ç®ãããŠããäžæ¹ã§ãå±éºæ§ãå¯äœçšã«é¢ããæžå¿µããããŸãã
çŸåšãããã«ãããèšåºè©Šéšã¯éãããŠãããååãªãšããã³ã¹ããªããããå®å
šæ§ã¯ç¢ºç«ãããŠããŸããã
å ±åãããŠããå¯äœçšã¯å°ãªããã®ã®ãCBGã®é·æçãªäœ¿çšãå€éæåã人äœã«äžãã圱é¿ã«ã€ããŠã®ããŒã¿ã¯äžè¶³ããŠããŸãã
ãŸããä»ã®è¬å€ãšã®çžäºäœçšã«é¢ããç ç©¶ãäžååã§ãããç¹å®ã®å¥åº·ç¶æ
ãæçšäžã®è¬å€ãããå Žåã«ã¯æ³šæãå¿
èŠã§ãã
CBG補åãšéžã³æ¹
CBGïŒã«ã³ããã²ããŒã«ïŒã®è£œåãéžã¶éã¯ãæåãšã¡ãŒã«ãŒã«çç®ããŠãã ããã
ãŸããTHCããªãŒã®è£œåãéžã¶ããšãå¿
é ã§ãã賌å
¥åã«è£œåã©ãã«ãæå衚瀺ã確èªãããTHCäžäœ¿çšããã0ïŒ
THCããšæèšãããŠãããã®ãéžã³ãŸãããã
次ã«ãä¿¡é Œæ§ãæ
ä¿ããããã第äžè
æ©é¢ã«ããæ€æ»ãåãã補åãéžã¶ããšãéèŠã§ãã
ãŸããå人茞å
¥åºãããªãã¢ããªã§ã®è³Œå
¥ã¯é¿ããæ£èŠè²©å£²åºãä¿¡é Œã§ãããªã³ã©ã€ã³ã·ã§ãããå©çšããŸããããéæ³åãåœç©ã®ãªã¹ã¯ãé²ãããã«ãã賌å
¥å
ã®éžå®ã倧åã§ãã
å®å šæ§ãéèŠããŠãªãã¬ãã·ã¥ããããªãDR.VAPE
CBGïŒã«ã³ããã²ããŒã«ïŒã¯ååœã§ç ç©¶ãé²ããããŠããŸããããšããã³ã¹ããŸã ååã§ãªãããã䜿çšã«äžå®ãæããæ¹ãå°ãªããããŸããã
å®å
šæ§ãéèŠãã€ã€ãªãã¬ãã·ã¥ãæ±ããæ¹ã«ã¯ãDR.VAPEãããããã§ãã
DR.VAPEã¯ã·ãªãŒãºçޝèšè²©å£²æ¬æ°3,000äžæ¬ãçªç Žããé»åã¿ãã³ã§ãã¿ãã³èãäžå䜿çšããŠããããäœã«æå®³ãªãã³ãã³ãã¿ãŒã«ã®å¿é
ããããŸããã
ææ°ã¢ãã«ã®DR.VAPE Model 3ã«ã¯ã倩ç¶ç±æ¥æåãβ-ã«ãªãªãã£ã¬ã³ããé
åã
β-ã«ãªãªãã£ã¬ã³ã¯ãåžãããšã§å¿èº«ãç©ããã«æŽãããæ¹ããæ³šç®ãéããŠããæåã§ãã
ãªããããã¬ãŒããŒã«ã¯9çš®é¡ã®è±å¯ãªããªãšãŒã·ã§ã³ããããåžãããããæºè¶³æãã£ã·ãã§ãã
|
ã¯ã€ã«ããã¿ãŒ ãã°ãç¬ç¹ã®çããšèŠã¿ã衚çŸ
|
ã¯ã©ã·ãã¯ã¹ã¢ãŒã¯ ã¹ã¢ãŒããŒã§åžãå¿å°ãããã¿ãã³å³
|
ãã³ãã¡ã³ãœãŒã« ãã£ããçœãããªã¡ã³ãœãŒã«å³
|
|
ãã¥ã¢ã¢ããã« çãã«ãã¬ã®ããã¢ããã«å³
|
ãžã¥ãŒã·ãŒãã¹ã«ãã è³éãªçããããµãããã¹ã«ããå³
|
ãªã©ãã¯ã¹ããã© ã³ã¯ã®ããå³ãããšæ¿åãªããã©ã®éŠã
|
|
ã¯ãªãŒããŒããã ãŸãããã§æ¿åãªãããã®å³ãã
|
ãããã«ã«ãã³ãŽãŒ ååœã®ãã³ãŽãŒã®ãããªãžã¥ãŒã·ãŒãªå³
|
ããã¯ã¹ããªãŒ ãã¬ãã·ã¥ã§çé žã£ã±ã3çš®ã®ããªãŒã衚çŸ
|
DR.VAPE Model 3ã¯ãé¢åãªæºåãã¡ã³ããã³ã¹ãäžèŠãªã®ãé
åã®ã²ãšã€ãããã€ã¹èšèšãæ¹è¯ãããåå¿è
ã§ãç°¡åã«æ±ãã仿§ãšãªã£ãŠããŸãã
賌å
¥ãç°¡åã§ãLINEãå©çšããå®æè³Œå
¥ãµãŒãã¹ãå©çšå¯èœãäºç®ã«åãããæè»ãªãã©ã³ã§çµæžçã«ãå®å¿ããŠç¶ããããŸãã
å€§éº»ç±æ¥æåã«å¯Ÿããäžå®ãæ±ããæ¹ããããå®å
šã§å¥åº·çãªæ¹æ³ã§ãªãã¬ãã·ã¥ã楜ãã¿ããæ¹ã¯DR.VAPEããã²ã詊ããã ããã